Raltegravir
ATC J05AJ01 · 9 markets · 40 records
US 10 records · 5 strengths
GB 9 records · 5 strengths
- 600 mgtabletISENTRESS__no_trade__
- 400 mgtabletISENTRESS__no_trade__
- 100 mgtabletIsentress 100mg chewable tablets
- 25 mgtabletIsentress 100mg chewable tablets
- 100 mgpowderIsentress 100mg granules for oral suspension sachets
ES 6 records · 5 strengths
- 600 mgtabletISENTRESSRALTEGRAVIR REDDYS
- 400 mgtabletRALTEGRAVIR REDDYS
- 100 mgtabletISENTRESS
- 25 mgtabletISENTRESS
- 60 mgtabletISENTRESS
AU 3 records · 3 strengths
- 600 mgtabletIsentress HD
- 400 mgtabletISENTRESS
Records without a stated strength · 1 Isentress and Isentress HD
CA 2 records · 2 strengths
- 600 mgtabletIsentress HD
- 400 mgtabletISENTRESS
HK 2 records · 1 strengths
Records without a stated strength · 1 ISENTRESS
CN 1 records · 1 strengths
- 434.4 mgtablet艾生特拉替拉韦
MX 1 records · 1 strengths
- 400 mgtabletTEVIXA
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 ISENTRESS
| Strength / form / release | US | GB | CA | AU | CN | ES | MX | HK | EU |
|---|---|---|---|---|---|---|---|---|---|
| 600 mg tablet | No trade name ISENTRESS | No trade name ISENTRESS | Isentress HD | Isentress HD | ISENTRESS RALTEGRAVIR REDDYS | ||||
| 400 mg tablet | No trade name ISENTRESS | No trade name ISENTRESS | ISENTRESS | ISENTRESS | RALTEGRAVIR REDDYS | TEVIXA | |||
| 100 mg tablet | ISENTRESS | Isentress 100mg chewable tablets | ISENTRESS | ||||||
| 25 mg tablet | ISENTRESS | Isentress 100mg chewable tablets | ISENTRESS | ||||||
| 100 mg powder | ISENTRESS | Isentress 100mg granules for oral suspension sachets | |||||||
| 434.4 mg tablet | 艾生特拉替拉韦 | ||||||||
| 60 mg tablet | ISENTRESS | ||||||||
unknown | Isentress and Isentress HD | ISENTRESS | ISENTRESS |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
2 more strength/form rows are recorded only in AU · CN · HK · EU and are not shown in this table. Hay 2 filas de concentración/forma registradas solo en AU · CN · HK · EU que no se muestran en esta tabla. 另有 2 个规格/剂型仅在 AU · CN · HK · EU 有记录(未在本表显示)。 另有 2 個規格/劑型僅在 AU · CN · HK · EU 有記錄(未在本表顯示)。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.